Hearing devices maker Cochlear Limited warns that Medicare's proposed rule change could limit access to certain cochlear implants.
A proposed change to Medicare's reimbursement of hearing aids could leave patients on their own when they need the a specific type of bone-anchored hearing aid implant, according to device maker Cochlear Ltd. (ASX:COH).
FDA medtech regulators decline a citizen petition to ban transvaginal mesh implants in the U.S., but "tentatively" agree that a reclassification may be in order to put the devices under more regulatory scrutiny.
FDA regulators refused this week to ban U.S. sales of pelvic mesh implants, rejecting in large part a petition filed by consumer advocacy group Public Citizen, but offered some consolation in a potential reclassification of the devices to a higher-risk category.
An new study shows that transcatheter aortic valve-in-valve implantation may be an important option for a growing population of patients with deteriorating bioprosthetic implants, but outcomes depend strongly on how the previous valve is failed.
New research released this week provides more support for the use of transcatheter aortic valve-in-valve (VIV) implantation as a means of replacing previously implanted valves that have deteriorated over time.
Abbott's MitraClip implant reduces mitral regurgitation and improves quality of life at 1 year in high-risk patients, according to new study results from the Everest II clinical trial.
High-risk patients with mitral regurgitation reduced their symptoms and reported better quality of life after treatment with Abbott's (NYSE:ABT) MitraClip implant, according to newly published results from the Everest II High Risk Registry.
Smith & Nephew integrates its partial knee implants with Blue Belt Technologies' Navio robot-assisted surgical system.
Valve leakage and cardiovascular mortality increased significantly over the course of a 3-year study of early high-risk patients treated with Medtronic's CoreValve TAVI system, but researchers insist the results are still "amazingly good."
Colorado device maker Encision finds itself fighting nearly 50 patient injury lawsuits related to surgical mesh products that it never manufactured or distributed.
Surgical devices maker Encision (PINK:ECIA) found itself the unfortunate target of nearly 50 lawsuits over alleged injuries caused by transvaginal mesh devices that Encision neither manufactures nor distributes.